{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:25:52Z","timestamp":1794000352593,"version":"4.8.0"},"reference-count":81,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) represent malignancies that arise from the transformation of immature precursor T cells. Similarities in T-LBL and T-ALL have raised the question whether these entities represent 1 disease or reflect 2 different diseases. The genetic profiles of T-ALL have been thoroughly investigated over the last 2 decades, whereas fairly little is known about genetic driver mutations in T-LBL. Nevertheless, the comparison of clinical, immunophenotypic, and molecular observations from independent T-LBL and T-ALL studies lent strength to the theory that T-LBL and T-ALL reflect different presentations of the same disease. Alternatively, T-LBL and T-ALL may simultaneously evolve from a common malignant precursor cell, each having their own specific pathogenic requirements or cellular dependencies that differ among stroma-embedded blasts in lymphoid tissues compared with solitary leukemia cells. This review aims to cluster recent findings with regard to clinical presentation, genetic predisposition, and the acquisition of additional mutations that may give rise to differences in gene expression signatures among T-LBL and T-ALL patients. Improved insight in T-LBL in relation to T-ALL may further help to apply confirmed T-ALL therapies to T-LBL patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001822","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T19:40:21Z","timestamp":1595965221000},"page":"3466-3473","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?"],"prefix":"10.1182","volume":"4","author":[{"given":"Emma","family":"Kroeze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L. C.","family":"Loeffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0933-853X","authenticated-orcid":false,"given":"Vera M.","family":"Poort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules P. P.","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"2020072811362920900_B1","first-page":"176","article-title":"In: Swerdlow SH, ed. WHO Classification of Tumours of Haemotopoietic and Lymphoid Tissues","author":"Borowitz","year":"2008","edition":"2nd ed"},{"issue":"5","key":"2020072811362920900_B2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"1","key":"2020072811362920900_B3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.leu.2404957","article-title":"Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences","volume":"22","author":"van Grotel","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"2020072811362920900_B4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children\u2019s Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br J Haematol"},{"key":"2020072811362920900_B5","doi-asserted-by":"crossref","first-page":"100647","DOI":"10.1016\/j.jbior.2019.100647","article-title":"Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients","volume":"74","author":"van der Zwet","year":"2019","journal-title":"Adv Biol Regul"},{"issue":"2","key":"2020072811362920900_B6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","article-title":"Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia","volume":"143","author":"Van Vlierberghe","year":"2008","journal-title":"Br J Haematol"},{"issue":"8","key":"2020072811362920900_B7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2020072811362920900_B8","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3324\/haematol.2015.139162","article-title":"Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma","volume":"102","author":"Landmann","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"2020072811362920900_B9","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"issue":"2","key":"2020072811362920900_B10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"issue":"6","key":"2020072811362920900_B11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjh.12460","article-title":"Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children\u2019s Oncology Group","volume":"162","author":"Termuhlen","year":"2013","journal-title":"Br J Haematol"},{"issue":"4","key":"2020072811362920900_B12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/ped.12725","article-title":"Treatment of pediatric lymphoma in Japan: Current status and plans for the future","volume":"57","author":"Kobayashi","year":"2015","journal-title":"Pediatr Int"},{"issue":"1","key":"2020072811362920900_B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"issue":"20","key":"2020072811362920900_B14","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","article-title":"Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group","volume":"27","author":"Burkhardt","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"2020072811362920900_B15","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-04-082040","article-title":"Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of \u201cisolated\u201d and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group","volume":"110","author":"Hagedorn","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2020072811362920900_B16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmg.2016.01.008","article-title":"Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool","volume":"59","author":"Jongmans","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"4","key":"2020072811362920900_B17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41571-018-0136-6","article-title":"Somatic and germline genomics in paediatric acute lymphoblastic leukaemia","volume":"16","author":"Pui","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"2020072811362920900_B18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejmg.2016.05.012","article-title":"Treatment of acute leukemia in children with ataxia telangiectasia (A-T)","volume":"59","author":"Schoenaker","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"12","key":"2020072811362920900_B19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3324\/haematol.2016.147116","article-title":"Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents","volume":"101","author":"Attarbaschi","year":"2016","journal-title":"Haematologica"},{"issue":"3","key":"2020072811362920900_B20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.2418","article-title":"Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation","volume":"216","author":"G\u0142adkowska-Dura","year":"2008","journal-title":"J Pathol"},{"issue":"12","key":"2020072811362920900_B21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/gcc.20924","article-title":"T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses","volume":"50","author":"Basso","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2020072811362920900_B22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bjh.13105","article-title":"Whole exome sequencing hints at a unique mutational profile of paediatric T-cell lymphoblastic lymphoma","volume":"168","author":"Bonn","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"2020072811362920900_B23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ccr.2010.09.009","article-title":"T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation","volume":"18","author":"Feng","year":"2010","journal-title":"Cancer Cell"},{"issue":"6","key":"2020072811362920900_B24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V57.6.1105.1105","article-title":"Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"57","author":"Bernard","year":"1981","journal-title":"Blood"},{"issue":"9","key":"2020072811362920900_B25","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/10428190701509772","article-title":"Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?","volume":"48","author":"Uyttebroeck","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2020072811362920900_B26","doi-asserted-by":"crossref","first-page":"e65373","DOI":"10.1371\/journal.pone.0065373","article-title":"Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia","volume":"8","author":"Borss\u00e9n","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"2020072811362920900_B27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-020-0310-9","article-title":"DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma","volume":"10","author":"Haider","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"2020072811362920900_B28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12935-018-0610-3","article-title":"PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression","volume":"18","author":"Xie","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2020072811362920900_B29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"issue":"2","key":"2020072811362920900_B30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","article-title":"Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951","volume":"103","author":"Cav\u00e9","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2020072811362920900_B31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/1078-0432.CCR-07-1927","article-title":"T cell receptor genotyping and HOXA\/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome","volume":"14","author":"Baleydier","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2020072811362920900_B32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10024-005-0050-7","article-title":"Cytogenetic findings in pediatric T-lymphoblastic lymphomas: one institution\u2019s experience and a review of the literature","volume":"8","author":"Ellison","year":"2005","journal-title":"Pediatr Dev Pathol"},{"issue":"16","key":"2020072811362920900_B33","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020072811362920900_B34","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3324\/haematol.2019.220863","article-title":"Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma","volume":"105","author":"Li","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"2020072811362920900_B35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08788.x","article-title":"Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia\/Lymphoma Study Group (JPLSG) and review of the literature","volume":"154","author":"Sekimizu","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"2020072811362920900_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2006.07.011","article-title":"Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08","volume":"172","author":"Lones","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"2020072811362920900_B37","first-page":"2615","article-title":"T-cell lymphoblastic leukemia\/lymphoma with t(7;14)(p15;q32) [TCR\u03b3-TCL1A translocation]: a case report and a review of the literature","volume":"7","author":"Sugimoto","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"2020072811362920900_B38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.2789","article-title":"Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"J Pathol"},{"issue":"3","key":"2020072811362920900_B39","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1016\/j.cub.2004.01.023","article-title":"Regulation of notch signaling activity","volume":"14","author":"Schweisguth","year":"2004","journal-title":"Curr Biol"},{"issue":"5694","key":"2020072811362920900_B40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"12","key":"2020072811362920900_B41","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/leu.2010.205","article-title":"NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951","volume":"24","author":"Clappier","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"2020072811362920900_B42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","article-title":"Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia","volume":"108","author":"Breit","year":"2006","journal-title":"Blood"},{"issue":"16","key":"2020072811362920900_B43","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","article-title":"Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence","volume":"121","author":"Bonn","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2020072811362920900_B44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.20122516","article-title":"The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia","volume":"210","author":"Mansour","year":"2013","journal-title":"J Exp Med"},{"issue":"64","key":"2020072811362920900_B45","doi-asserted-by":"crossref","first-page":"107886","DOI":"10.18632\/oncotarget.22386","article-title":"Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma","volume":"8","author":"Pomari","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2020072811362920900_B46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1098-2264(199905)25:1<60::AID-GCC9>3.0.CO;2-Y","article-title":"Identification of three commonly deleted regions on chromosome arm 6q in human pancreatic cancer","volume":"25","author":"Abe","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"2020072811362920900_B47","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/sj.leu.2402640","article-title":"Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia","volume":"16","author":"Mancini","year":"2002","journal-title":"Leukemia"},{"issue":"9","key":"2020072811362920900_B48","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1182\/blood.V91.9.3397","article-title":"6q deletions in acute lymphoblastic leukemia and non-Hodgkin\u2019s lymphomas","volume":"91","author":"Merup","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2020072811362920900_B49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/10428190701824551","article-title":"Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact","volume":"49","author":"Burkhardt","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2020072811362920900_B50","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/2159-8290.CD-17-0831","article-title":"Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation","volume":"8","author":"Gachet","year":"2018","journal-title":"Cancer Discov"},{"issue":"5-6","key":"2020072811362920900_B51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10428190009148394","article-title":"Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group","volume":"36","author":"Heerema","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2020072811362920900_B52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/carcin\/bgr271","article-title":"EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas","volume":"33","author":"L\u00f3pez-Nieva","year":"2012","journal-title":"Carcinogenesis"},{"issue":"12","key":"2020072811362920900_B53","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1158\/0008-5472.CAN-03-1871","article-title":"A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene","volume":"64","author":"Sinclair","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"2020072811362920900_B54","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","article-title":"High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response","volume":"114","author":"Remke","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2020072811362920900_B55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat Genet"},{"key":"2020072811362920900_B56","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.biopha.2018.11.083","article-title":"The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone","volume":"109","author":"Xiang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2020072811362920900_B57","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3324\/haematol.2011.043083","article-title":"Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia","volume":"96","author":"Wang","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"2020072811362920900_B58","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/eji.200535760","article-title":"Critical role for c-kit (CD117) in T cell lineage commitment and early thymocyte development in vitro","volume":"36","author":"Massa","year":"2006","journal-title":"Eur J Immunol"},{"issue":"2","key":"2020072811362920900_B59","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4049\/jimmunol.173.2.1094","article-title":"Analysis of transcription factor expression during discrete stages of postnatal thymocyte differentiation","volume":"173","author":"Tabrizifard","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"2020072811362920900_B60","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1182\/blood.V88.11.4239.bloodjournal88114239","article-title":"Interleukin-7 is a critical growth factor in early human T-cell development","volume":"88","author":"Plum","year":"1996","journal-title":"Blood"},{"issue":"5","key":"2020072811362920900_B61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1084\/jem.20040789","article-title":"Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells","volume":"200","author":"Barata","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"2020072811362920900_B62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood.V96.1.297","article-title":"Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical\/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia","volume":"96","author":"Karawajew","year":"2000","journal-title":"Blood"},{"key":"2020072811362920900_B63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbior.2018.09.012","article-title":"IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update","volume":"71","author":"Oliveira","year":"2019","journal-title":"Adv Biol Regul"},{"issue":"9","key":"2020072811362920900_B64","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/leu.2016.83","article-title":"MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia","volume":"30","author":"Cant\u00e9-Barrett","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"2020072811362920900_B65","doi-asserted-by":"crossref","first-page":"e1002200","DOI":"10.1371\/journal.pmed.1002200","article-title":"IL-7 receptor mutations and steroid resistance in pediatric T cell acute lymphoblastic leukemia: a genome sequencing study","volume":"13","author":"Li","year":"2016","journal-title":"PLoS Med"},{"issue":"12","key":"2020072811362920900_B66","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"issue":"34","key":"2020072811362920900_B67","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020072811362920900_B68","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1038\/bcj.2017.3","article-title":"Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia","volume":"7","author":"Richter-Pecha\u0144ska","year":"2017","journal-title":"Blood Cancer J"},{"issue":"4","key":"2020072811362920900_B69","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2015.203","article-title":"Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia","volume":"30","author":"Balbach","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"2020072811362920900_B70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.leu.2403272","article-title":"RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia","volume":"18","author":"Perentesis","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"2020072811362920900_B71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood-2014-03-562751","article-title":"PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events","volume":"124","author":"Mendes","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2020072811362920900_B72","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3324\/haematol.2011.059030","article-title":"The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia","volume":"97","author":"Zuurbier","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"2020072811362920900_B73","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bjh.15449","article-title":"The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols","volume":"182","author":"Paganin","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"2020072811362920900_B74","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1038\/leu.2017.157","article-title":"Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia","volume":"31","author":"Tesio","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"2020072811362920900_B75","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1002\/ajh.25396","article-title":"PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols. PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols","volume":"94","author":"Szarzy\u0144ska-Zawadzka","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"2020072811362920900_B76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/leu.2015.206","article-title":"Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial","volume":"30","author":"Jenkinson","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"2020072811362920900_B77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/leu.2009.209","article-title":"Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia","volume":"24","author":"Jotta","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"2020072811362920900_B78","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3324\/haematol.2012.073585","article-title":"NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia","volume":"98","author":"Bandapalli","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"2020072811362920900_B79","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"2020072811362920900_B80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.advenzreg.2010.09.012","article-title":"The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival","volume":"51","author":"Barata","year":"2011","journal-title":"Adv Enzyme Regul"},{"issue":"12","key":"2020072811362920900_B81","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/leu.2010.204","article-title":"NOTCH1 and\/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols","volume":"24","author":"Zuurbier","year":"2010","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/14\/3466\/1750255\/advancesadv2020001822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/14\/3466\/1750255\/advancesadv2020001822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T19:41:26Z","timestamp":1595965286000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/14\/3466\/461579\/Tcell-lymphoblastic-lymphoma-and-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":81,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,7,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001822","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]}}}